Pharmacologic management of psychosis in dementia.
Significant consequences of untreated psychosis in patients with dementia have led clinicians to seek improved therapeutic options. This review presents the scope of the problem, discusses some of the underlying neurobiology, and highlights the evidence for appropriate therapies. A range of potentially effective pharmacologic therapies is available and is discussed.
Schneider
L S
LS
Department of Psychiatry, University of Southern California School of Medicine, Los Angeles 90033, USA.
D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003024:Clozapine / Q000627:therapeutic use; D015897:Comorbidity; D003702:Delusions / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D003704:Dementia / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D006212:Hallucinations / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D006801:Humans; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D018967:Risperidone / Q000627:therapeutic use; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003024:Clozapine; D018967:Risperidone